PAIN & NEURAL DYSFUNCTION FROM ACUTE HERPES ZOSTER
疼痛
基本信息
- 批准号:6629326
- 负责人:
- 金额:$ 13.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-02-01 至 2005-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Pain, nerve trunk inflammation, and neuronal injury are hallmarks of acute herpes zoster (AHZ or 'shingles'). The majority of patients with AHZ recover uneventfully, but a minority develop enduring neuropathic pain - in the form of post-herpetic neuralgia (PHN). Age, initial pain severity, and psychosocial factors have been established as risk factors for PHN in longitudinal studies, but evolution of neural dysfunction and deafferentation, the hallmarks of the chronic neuropathic pain of PHN, have received little study. We hypothesize that the development of post-herpetic neuralgia strongly depends on two factors: 1) the severity of the initial neural injury and 2) the ability to recover from the initial neural injury. To test this hypothesis, we will prospectively follow 200 patients with AHZ at high risk for development of PHN. Study participants will be followed closely from 2 weeks after the onset of AHZ to 6 months post-zoster, a time when PHN is well established and unlikely to remit spontaneously. Evolution of pain and neural injury will be evaluated at 2 weeks, 1 month, 3 months, and 6 months after the onset of AHZ. At study visits, assessments will include ratings of pain intensity, mood, quality of life, allodynia severity, mapping the extent of skin affected by lesions, pain, and allodynia, quantitative tests of sensory function, and response to controlled applications of capsaicin. Loss and possible recovery of cutaneous nerve fibers will be documented through serial skin punch biopsies stained for the axonal marker PGP 9.5 in affected and normal skin. Abnormal neural function in remaining fibers will be evident as allodynia, hyperalgesia to mechanical and thermal stimuli, and hyperalgesia to capsaicin application. Signs of loss of primary afferent nociceptor function will be evident as inability to perceive noxious heat and capsaicin. The importance of neural dysfunction and neuronal loss as risk factors for PHN will be compared to risk factors found in other studies.
疼痛、神经干炎症和神经元损伤是急性带状疱疹(AHZ或带状疱疹)的特征。大多数AHZ患者恢复平静,但少数发展持久的神经性疼痛-在疱疹后神经痛(PHN)的形式。在纵向研究中,年龄、初始疼痛严重程度和社会心理因素已被确定为PHN的危险因素,但作为PHN慢性神经性疼痛的标志,神经功能障碍和神经传递障碍的演变却很少得到研究。我们假设疱疹后神经痛的发生主要取决于两个因素:1)初始神经损伤的严重程度和2)从初始神经损伤中恢复的能力。为了验证这一假设,我们将对200名AHZ患者进行前瞻性随访,这些患者有发展为PHN的高风险。研究参与者将在AHZ发病后2周至带状疱疹后6个月期间密切随访,此时PHN已经建立,不太可能自行消退。在AHZ发病后2周、1个月、3个月和6个月评估疼痛和神经损伤的演变情况。在研究访问中,评估将包括疼痛强度、情绪、生活质量、异位性疼痛严重程度的评分,绘制皮肤病变、疼痛和异位性疼痛的影响程度,感觉功能的定量测试,以及对辣椒素控制应用的反应。皮神经纤维的损失和可能的恢复将通过连续的皮肤穿刺活检来记录,在受影响和正常皮肤中染色轴突标记物PGP 9.5。剩余纤维的异常神经功能将表现为对机械和热刺激的异常痛觉,以及对辣椒素应用的痛觉过敏。初级传入伤害感受器功能丧失的迹象将表现为无法感知有害热量和辣椒素。神经功能障碍和神经元丢失作为PHN危险因素的重要性将与其他研究中发现的危险因素进行比较。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Relief of post-herpetic neuralgia by surgical removal of painful skin: 5 years later.
通过手术切除疼痛皮肤缓解带状疱疹后神经痛:5 年后。
- DOI:10.1016/j.pain.2007.03.004
- 发表时间:2007
- 期刊:
- 影响因子:7.4
- 作者:Petersen,KarinLottrup;Rowbotham,MichaelC
- 通讯作者:Rowbotham,MichaelC
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Karin L Petersen其他文献
Karin L Petersen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Karin L Petersen', 18)}}的其他基金
Gabapentin for the Pain of Acute Herpes Zoster
加巴喷丁治疗急性带状疱疹的疼痛
- 批准号:
6972289 - 财政年份:2004
- 资助金额:
$ 13.01万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 13.01万 - 项目类别:
Research Grant
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 13.01万 - 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 13.01万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 13.01万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 13.01万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 13.01万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 13.01万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 13.01万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 13.01万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 13.01万 - 项目类别: